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Searchable Question 
What clinical findings can be used to diagnose deep venous thrombosis (DVT)? 
Evidence-Based Answer 
No single clinical finding can accurately diagnose DVT. [Strength of recommendation: A, based 
on a systematic review of homogeneous validating cohort studies with good reference standards] 
However, when organized into clinical decision rules (CDRs), clinical findings can reliably 
differentiate patients into categories of low, moderate, or high probability of having DVT. 
[Strength of recommendation: A, based on numerous studies of CDRs from different clinical 
centers] 
Evidence Summary 
A 1998 systematic review1 concluded that individual signs and symptoms cannot reliably 
diagnose DVT. [Evidence level 1A] Combining specific risk factors, symptoms, and physical 
signs into a CDR increases diagnostic accuracy. The best-studied CDR is the Wells model (see 
accompanying table). The Agency for Healthcare Research and Quality (AHRQ) reported that 
the Wells CDR accurately classified patients per probability of DVT-low (zero to 13 percent 
chance), moderate (13 to 30 percent chance) or high (49 to 81 percent chance)-in 11 of 12 
studies.2 [Evidence level 1A] The AHRQ report was limited in that all of the reviewed studies 
were published in the English language, most excluded patients with a history of DVT, and some 
had methodologic flaws. 
 
Wells Clinical Decision Rule 
 
Clinical characteristic Score 
Active cancer (treatment ongoing or within previous six months or palliative) 1 
Paralysis, paresis, or recent plaster immobilization of the lower extremities 1 
Recently bedridden for more than three days or major surgery within 12 weeks 
requiring general or regional anesthesia 
1 
Localized tenderness along the distribution of the deep venous system 1 
Entire leg swollen 1 
Calf swelling 3 cm larger than asymptomatic side (circumference measured 10 cm 
below tibial tuberosity) 
1 
Pitting edema confined to the symptomatic leg 1 
Collateral superficial veins (nonvaricose) 1 
Previously documented DVT 1 
Alternative diagnosis at least as likely as DVT -2 
 
 
NOTE: To determine the probability of DVT, calculate the score and place the patient in one of the 
following categories: a score of zero = low (zero to 13 percent probability); 1 to 2 = moderate (13 to 
30 percent probability); >= 3 = high (49 to 81 percent probability). In patients with symptoms in both 
legs, the more symptomatic leg is used. An additional characteristic, "previously documented DVT," 
was added in 2003, but the new rule has not been extensively tested. 
DVT = deep venous thrombosis. 
Information from references 1 and 2. 
 
 
The results of four recently published studies3-6 of the Wells CDR are consistent with the 
AHRQ findings. [References 3 through 6-Evidence level 1B] It is important to note that, when 
using only the Wells CDR, DVT cannot be ruled out completely in patients with a low 
probability score or confirmed in patients with a high probability score. However, use of such a 
CDR can help inform interpretation of subsequent diagnostic tests and reduce the need for 
invasive testing. 
The Wells CDR is more accurate than the Kahn and St. André CDRs and is comparable to the 
Ambulatory CDR.6 Two studies3,7 have shown that empirically assigning patients to low-, 
moderate-, or high-probability groups based on established clinical criteria is as accurate as 
formal use of the Wells CDR. [Reference 7-Evidence level 1B] 
Recommendations from Others 
The Finnish Medical Society recommends using a CDR that is similar to the Wells CDR during 
the initial evaluation of patients suspected of having DVT.8 The most recent American Thoracic 
Society guideline (published in 1999, before most of the studies evaluating CDRs for DVT were 
available), states that the clinical evaluation cannot be relied on to confirm or exclude the 
diagnosis of DVT.9  
Clinical Commentary 
Physicians should use this evidence to decide how aggressively to pursue the diagnosis of 
suspected DVT. For example, a patient with a low clinical probability of DVT and a normal 
initial noninvasive diagnostic test (D-dimer or ultrasonography) may require only observation, 
whereas a patient with a high clinical probability and a normal initial noninvasive diagnostic test 
may require serial ultrasonography or venography. 
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